Stock Scorecard
Stock Summary for Organon & Company (OGN) - $6.93 as of 4/10/2026 6:35:48 PM EST
Total Score
10 out of 30
Safety Score
23 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for OGN
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for OGN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for OGN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for OGN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for OGN (23 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for OGN
Financial Details for OGN
Company Overview |
|
|---|---|
| Ticker | OGN |
| Company Name | Organon & Company |
| Country | N/A |
| Description | Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - GENERAL |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 5/7/2026 |
Stock Price History |
|
| Last Day Price | 6.93 |
| Price 4 Years Ago | 24.05 |
| Last Day Price Updated | 4/10/2026 6:35:48 PM EST |
| Last Day Volume | 10,019,134 |
| Average Daily Volume | 3,732,685 |
| 52-Week High | 13.12 |
| 52-Week Low | 5.69 |
| Last Price to 52 Week Low | 21.79% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 31.53 |
| Sector PE | 116.07 |
| 5-Year Average PE | 2.69 |
| Free Cash Flow Ratio | 3.14 |
| Industry Free Cash Flow Ratio | 48.65 |
| Sector Free Cash Flow Ratio | 26.96 |
| Current Ratio Most Recent Quarter | 1.82 |
| Total Cash Per Share | 2.21 |
| Book Value Per Share Most Recent Quarter | 2.89 |
| Price to Book Ratio | 2.20 |
| Industry Price to Book Ratio | 11.44 |
| Sector Price to Book Ratio | 19.97 |
| Price to Sales Ratio Twelve Trailing Months | 0.27 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.34 |
| Sector Price to Sales Ratio Twelve Trailing Months | 24.62 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 260,316,000 |
| Market Capitalization | 1,803,989,880 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 2/23/2026 |
| Previous Dividend Amount | 0.0200 |
| Current Dividend Amount | 0.0200 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.08 |
| Trailing Annual Dividend Yield | 1.26% |
| Forward Annual Dividend Rate | 0.08 |
| Forward Annual Dividend Yield | 1.26% |
| 5-Year Dividend Payments Count | 19 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | -76.47% |
| 3-Year Dividend Growth Rate Percentage | -51.49% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | -32.79% |
| Dividend Payout Ratio | 11.11% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -55.80% |
| Annual Earnings Growth | -78.36% |
| Reported EPS 12 Trailing Months | 0.72 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 3.66 |
| Net Income Twelve Trailing Months | 187,000,000 |
| Net Income Past Year | 187,000,000 |
| Net Income Prior Year | 864,000,000 |
| Quarterly Revenue Growth YOY | -5.30% |
| 5-Year Revenue Growth | -0.99% |
| Operating Margin Twelve Trailing Months | 16.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 574,000,000 |
| Total Cash Past Year | 574,000,000 |
| Total Cash Prior Year | 675,000,000 |
| Net Cash Position Most Recent Quarter | -8,054,000,000 |
| Net Cash Position Past Year | -8,054,000,000 |
| Long Term Debt Past Year | 8,628,000,000 |
| Long Term Debt Prior Year | 8,860,000,000 |
| Total Debt Most Recent Quarter | 8,628,000,000 |
| Equity to Debt Ratio Past Year | 0.08 |
| Equity to Debt Ratio Most Recent Quarter | 0.08 |
| Total Stockholder Equity Past Year | 752,000,000 |
| Total Stockholder Equity Prior Year | 472,000,000 |
| Total Stockholder Equity Most Recent Quarter | 752,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 404,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.55 |
| Free Cash Flow Past Year | 538,000,000 |
| Free Cash Flow Prior Year | 588,000,000 |
Options |
|
| Put/Call Ratio | 0.09 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.64 |
| RSI | 0.00 |
| 50-Day SMA | 8.58 |
| 150-Day SMA | 13.83 |
| 200-Day SMA | 16.23 |
System |
|
| Modified | 4/11/2026 5:20:53 AM EST |